---
schema_version: "secwatch.filing_event.v1"
accession: "0001376339-26-000070"
form_type: "8-K"
ticker: "MDXG"
cik: "0001376339"
company_name: "MIMEDX GROUP, INC."
filed_at: "2026-07-29T20:03:54+00:00"
generated_at: "2026-07-29T20:05:11.005393+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# MiMedx to acquire Sanara MedTech for $35/share in cash and stock, ~$350M enterprise value

## Summary
- MiMedx to acquire Sanara MedTech for $35 per share ($33 cash + 0.4735 MDXG shares), total enterprise value ~$350M.
- Transaction expected to be immediately accretive to revenue growth, gross margin, and adjusted EBITDA margin; over $20M in run-rate cost synergies.
- MiMedx secured $300M debt commitment from Hayfin Capital Management to finance cash consideration and refinance existing debt.
- Sanara stockholders holding ~38.9% of voting power have agreed to vote in favor via voting agreement.
- Closing expected late 2026/early 2027, subject to Sanara stockholder approval, HSR clearance, and other conditions.

## SEC filing metadata
- accession: 0001376339-26-000070
- form_type: 8-K
- ticker: MDXG
- cik: 0001376339
- company_name: MIMEDX GROUP, INC.
- filed_at: 2026-07-29T20:03:54+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1376339/000137633926000070/0001376339-26-000070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1376339/000137633926000070/mdxg-20260729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001376339-26-000070
- JSON: https://secwatch.observer/filing/0001376339-26-000070.json
- Plain text: https://secwatch.observer/filing/0001376339-26-000070.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.